Cargando…
Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial
The performance of blood culture for monitoring candidemia clearance is hampered by its low sensitivity, especially during antifungal therapy. The T2 magnetic resonance (T2MR) assay combines magnetic resonance with nanotechnology to identify whole Candida species cells. A multicenter clinical trial...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869839/ https://www.ncbi.nlm.nih.gov/pubmed/29367293 http://dx.doi.org/10.1128/JCM.01756-17 |
_version_ | 1783309352081293312 |
---|---|
author | Mylonakis, Eleftherios Zacharioudakis, Ioannis M. Clancy, Cornelius J. Nguyen, M. Hong Pappas, Peter G. |
author_facet | Mylonakis, Eleftherios Zacharioudakis, Ioannis M. Clancy, Cornelius J. Nguyen, M. Hong Pappas, Peter G. |
author_sort | Mylonakis, Eleftherios |
collection | PubMed |
description | The performance of blood culture for monitoring candidemia clearance is hampered by its low sensitivity, especially during antifungal therapy. The T2 magnetic resonance (T2MR) assay combines magnetic resonance with nanotechnology to identify whole Candida species cells. A multicenter clinical trial studied the performance of T2MR in monitoring candidemia clearance compared to blood culture. Adults with a blood culture positive for yeast were enrolled and had blood cultures and T2MR testing performed on prespecified days. Thirty-one patients completed the trial. Thirteen of the 31 patients (41.9%) had at least one positive surveillance T2MR and/or blood culture result. All positive blood cultures (7/7 [100%]) had an accompanying positive T2MR result with concordance in the identified Candida sp., while only 7/23 (30.4%) T2MR results had an accompanying positive blood culture. There was one case of discordance in species identification between T2MR and the preenrollment blood culture with evidence to support deep-seated infection by the Candida spp. detected by the T2MR assay. Based on the log rank test, there was a statistically significant improvement in posttreatment surveillance using the T2MR assay compared to blood culture (P = 0.004). Limitations of the study include the small sample size and lack of outcome data. In conclusion, the T2MR assay significantly outperformed blood cultures for monitoring the clearance of candidemia in patients receiving antifungal therapy and may be useful in determining adequate source control, timing for deescalation, and optimal duration of treatment. However, further studies are needed to determine the viability of Candida species cells detected by the T2MR assay and correlate the results with patient outcomes. (This study is registered at ClinicalTrials.gov under registration number NCT02163889.) |
format | Online Article Text |
id | pubmed-5869839 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-58698392018-04-06 Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial Mylonakis, Eleftherios Zacharioudakis, Ioannis M. Clancy, Cornelius J. Nguyen, M. Hong Pappas, Peter G. J Clin Microbiol Mycology The performance of blood culture for monitoring candidemia clearance is hampered by its low sensitivity, especially during antifungal therapy. The T2 magnetic resonance (T2MR) assay combines magnetic resonance with nanotechnology to identify whole Candida species cells. A multicenter clinical trial studied the performance of T2MR in monitoring candidemia clearance compared to blood culture. Adults with a blood culture positive for yeast were enrolled and had blood cultures and T2MR testing performed on prespecified days. Thirty-one patients completed the trial. Thirteen of the 31 patients (41.9%) had at least one positive surveillance T2MR and/or blood culture result. All positive blood cultures (7/7 [100%]) had an accompanying positive T2MR result with concordance in the identified Candida sp., while only 7/23 (30.4%) T2MR results had an accompanying positive blood culture. There was one case of discordance in species identification between T2MR and the preenrollment blood culture with evidence to support deep-seated infection by the Candida spp. detected by the T2MR assay. Based on the log rank test, there was a statistically significant improvement in posttreatment surveillance using the T2MR assay compared to blood culture (P = 0.004). Limitations of the study include the small sample size and lack of outcome data. In conclusion, the T2MR assay significantly outperformed blood cultures for monitoring the clearance of candidemia in patients receiving antifungal therapy and may be useful in determining adequate source control, timing for deescalation, and optimal duration of treatment. However, further studies are needed to determine the viability of Candida species cells detected by the T2MR assay and correlate the results with patient outcomes. (This study is registered at ClinicalTrials.gov under registration number NCT02163889.) American Society for Microbiology 2018-03-26 /pmc/articles/PMC5869839/ /pubmed/29367293 http://dx.doi.org/10.1128/JCM.01756-17 Text en Copyright © 2018 Mylonakis et al. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Mycology Mylonakis, Eleftherios Zacharioudakis, Ioannis M. Clancy, Cornelius J. Nguyen, M. Hong Pappas, Peter G. Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial |
title | Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial |
title_full | Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial |
title_fullStr | Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial |
title_full_unstemmed | Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial |
title_short | Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) Trial |
title_sort | efficacy of t2 magnetic resonance assay in monitoring candidemia after initiation of antifungal therapy: the serial therapeutic and antifungal monitoring protocol (stamp) trial |
topic | Mycology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869839/ https://www.ncbi.nlm.nih.gov/pubmed/29367293 http://dx.doi.org/10.1128/JCM.01756-17 |
work_keys_str_mv | AT mylonakiseleftherios efficacyoft2magneticresonanceassayinmonitoringcandidemiaafterinitiationofantifungaltherapytheserialtherapeuticandantifungalmonitoringprotocolstamptrial AT zacharioudakisioannism efficacyoft2magneticresonanceassayinmonitoringcandidemiaafterinitiationofantifungaltherapytheserialtherapeuticandantifungalmonitoringprotocolstamptrial AT clancycorneliusj efficacyoft2magneticresonanceassayinmonitoringcandidemiaafterinitiationofantifungaltherapytheserialtherapeuticandantifungalmonitoringprotocolstamptrial AT nguyenmhong efficacyoft2magneticresonanceassayinmonitoringcandidemiaafterinitiationofantifungaltherapytheserialtherapeuticandantifungalmonitoringprotocolstamptrial AT pappaspeterg efficacyoft2magneticresonanceassayinmonitoringcandidemiaafterinitiationofantifungaltherapytheserialtherapeuticandantifungalmonitoringprotocolstamptrial |